July 3 2025 - Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda

Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda
AstraZeneca board
Intuitive Surgical’s da Vinci 5 robot wins CE mark
Intuitive Surgical board
Novartis drug flunks phase 3 test in giant cell arteritis
Novartis board
Bluebird go-private deal signals the ‘PE-ization of pharma’
General Pharma Discussion board
*please scroll down for all the latest news*

Check open job listings in your area
Click here to get the top four headlines in your inbox Mon-Fri (free)

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud